Why is female sex an independent predictor of shortened overall survival after proton/photon radiation therapy for skull base chordomas? 来自 Semantic Scholar 喜欢 0 阅读量: 46 作者: EC Halperin 摘要: Diethylenetriamine pentaacetic acid (DTPA) has been tested with 8 other new chelators for neptun...
" said Buchsbaum. "That's why these randomized trials are so important. We need the evidence from these trials to determine whether proton therapy is better than usual care at reducing side effects or extending survival."
Why is female sex an independent predictor of shortened overall survival after proton/photon radiation therapy for skull base chordromas? Int J Radiat Oncol Biol Phys 1997;38:225-30.Halperin, EC (1997) Why is female sex an independent predictor of shortened overall survival after proton/photon ...
Cutthroat Competition: Varian competes with large electronic companies such as Siemens and Philips as well as smaller and more specialized radiation therapy equipment manufacturers like Elekta, Accuray, Medtronic and Stryker. Estimate Trend For fiscal 2021, the Zacks Consensus Estimate for revenues is pe...
Texas Center for Proton Therapyopened in late 2015 in Irving, Texas, located in the heart of the Dallas-Fort Worth Metroplex. The center, featuring latest-generation technology, provides Texas Oncology physicians another advanced radiation treatment option. ...
Cell populations that emerge from this evolutionary sequence have a powerful growth advantage, as they alter their environment through increased glycolysis in a way that is toxic to other phenotypes, but harmless to themselves. The environmental acidosis also facilitates invasion through destruction of ad...
Clinical trials using single high doses up to 300 mg/kg as adjuvant to radiation therapy for glioblastoma patients was tolerated [58,59], but for longer term adjuvant treatment, only lower doses up to 63 mg/kg is tolerated [60], which may be too low dose to achieve efficacy. The ...